Search research articles
Contact Us
Filters
Showing results (201-210 of 231) with videos related to
Page
of 24
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics
|
May 28, 2019
Effects of Extended-Release Niacin on Quartile Lp-PLA<sub>2</sub> Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial
Radmila Lyubarova, John J Albers, Santica M Marcovina, et al.
American Heart Journal
|
April 27, 2020
Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease
William E Boden, Michael G Miller, Ruth McBride, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 14, 2004
Fermented beverages of pre- and proto-historic China
Patrick E McGovern, Juzhong Zhang, Jigen Tang, et al.
Antiviral Therapy
|
February 17, 2007
Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148
Michael P Dubé, Julia W Wu, Judith A Aberg, et al.
Fetal Diagnosis and Therapy
|
June 29, 2018
Chronically Hypoxic Fetal Lambs Supported by an Extra-Uterine Device Exhibit Mitochondrial Dysfunction and Elevations of Hypoxia Inducible Factor 1-Alpha
Avery C Rossidis, Heron D Baumgarten, Kendall M Lawrence, et al.
Archives of Internal Medicine
|
July 19, 2002
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial
Scott M Grundy, Gloria Lena Vega, Mark E McGovern, et al.
The American Journal of Cardiology
|
March 19, 2002
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia
Moti L Kashyap, Mark E McGovern, Kathleen Berra, et al.
Canadian Liver Journal
|
August 22, 2022
Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective study
Brian Conway, Julie Bruneau, Curtis Cooper, et al.
Fetal Diagnosis and Therapy
|
February 1, 2019
Erythropoietin Prevents Anemia and Transfusions in Extremely Premature Lambs Supported by an EXTrauterine Environment for Neonatal Development (EXTEND)
Ali Y Mejaddam, Matthew A Hornick, Patrick E McGovern, et al.
Journal of General Internal Medicine
|
October 18, 2024
Patient Perceptions on the Follow-Up of Abnormal Cancer Screening Test Results
Steven J Atlas, Katherine L Gallagher, Sydney E McGovern, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 231) with videos related to
Sort By:
Page
of 24
Journal of Cardiovascular Pharmacology and Therapeutics
|
May 28, 2019
Effects of Extended-Release Niacin on Quartile Lp-PLA<sub>2</sub> Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial
Radmila Lyubarova, John J Albers, Santica M Marcovina, et al.
American Heart Journal
|
April 27, 2020
Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease
William E Boden, Michael G Miller, Ruth McBride, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 14, 2004
Fermented beverages of pre- and proto-historic China
Patrick E McGovern, Juzhong Zhang, Jigen Tang, et al.
Antiviral Therapy
|
February 17, 2007
Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148
Michael P Dubé, Julia W Wu, Judith A Aberg, et al.
Fetal Diagnosis and Therapy
|
June 29, 2018
Chronically Hypoxic Fetal Lambs Supported by an Extra-Uterine Device Exhibit Mitochondrial Dysfunction and Elevations of Hypoxia Inducible Factor 1-Alpha
Avery C Rossidis, Heron D Baumgarten, Kendall M Lawrence, et al.
Archives of Internal Medicine
|
July 19, 2002
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial
Scott M Grundy, Gloria Lena Vega, Mark E McGovern, et al.
The American Journal of Cardiology
|
March 19, 2002
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia
Moti L Kashyap, Mark E McGovern, Kathleen Berra, et al.
Canadian Liver Journal
|
August 22, 2022
Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective study
Brian Conway, Julie Bruneau, Curtis Cooper, et al.
Fetal Diagnosis and Therapy
|
February 1, 2019
Erythropoietin Prevents Anemia and Transfusions in Extremely Premature Lambs Supported by an EXTrauterine Environment for Neonatal Development (EXTEND)
Ali Y Mejaddam, Matthew A Hornick, Patrick E McGovern, et al.
Journal of General Internal Medicine
|
October 18, 2024
Patient Perceptions on the Follow-Up of Abnormal Cancer Screening Test Results
Steven J Atlas, Katherine L Gallagher, Sydney E McGovern, et al.
Page
of 24